RPG Life Sciences Limited (RPGLIFE) - Total Liabilities
Based on the latest financial reports, RPG Life Sciences Limited (RPGLIFE) has total liabilities worth Rs1.52 Billion INR (≈ $16.41 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore RPGLIFE cash generation efficiency to assess how effectively this company generates cash.
RPG Life Sciences Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how RPG Life Sciences Limited's total liabilities have evolved over time, based on quarterly financial data. Check RPG Life Sciences Limited (RPGLIFE) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
RPG Life Sciences Limited Competitors by Total Liabilities
The table below lists competitors of RPG Life Sciences Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ophir High Conviction Fund
AU:OPH
|
Australia | AU$28.68 Million |
|
Fastned B.V.
AS:FAST
|
Netherlands | €362.97 Million |
|
Guangdong Anjubao Digital Tech
SHE:300155
|
China | CN¥138.36 Million |
|
Priority Technology Holdings Inc
NASDAQ:PRTH
|
USA | $2.49 Billion |
|
Gladstone Land Corporation
NASDAQ:LAND
|
USA | $568.89 Million |
|
Jiangsu Wanlin Modern Logistic
SHG:603117
|
China | CN¥317.29 Million |
|
Taiwan Mask Corp
TW:2338
|
Taiwan | NT$13.60 Billion |
|
Luxfer Holdings PLC
NYSE:LXFR
|
USA | $145.80 Million |
Liability Composition Analysis (2005–2025)
This chart breaks down RPG Life Sciences Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see RPG Life Sciences Limited (RPGLIFE) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 0.92 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RPG Life Sciences Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RPG Life Sciences Limited (2005–2025)
The table below shows the annual total liabilities of RPG Life Sciences Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | Rs1.27 Billion ≈ $13.76 Million |
-7.78% |
| 2024-03-31 | Rs1.38 Billion ≈ $14.93 Million |
+23.51% |
| 2023-03-31 | Rs1.12 Billion ≈ $12.09 Million |
+25.79% |
| 2022-03-31 | Rs888.40 Million ≈ $9.61 Million |
+2.19% |
| 2021-03-31 | Rs869.40 Million ≈ $9.40 Million |
-3.57% |
| 2020-03-31 | Rs901.60 Million ≈ $9.75 Million |
-0.64% |
| 2019-03-31 | Rs907.40 Million ≈ $9.81 Million |
-33.53% |
| 2018-03-31 | Rs1.37 Billion ≈ $14.76 Million |
+48.09% |
| 2017-03-31 | Rs921.90 Million ≈ $9.97 Million |
+28.69% |
| 2016-03-31 | Rs716.40 Million ≈ $7.75 Million |
-0.15% |
| 2015-03-31 | Rs717.50 Million ≈ $7.76 Million |
+2.05% |
| 2014-03-31 | Rs703.10 Million ≈ $7.60 Million |
-45.72% |
| 2013-03-31 | Rs1.30 Billion ≈ $14.01 Million |
+19.10% |
| 2012-03-31 | Rs1.09 Billion ≈ $11.76 Million |
-6.29% |
| 2011-03-31 | Rs1.16 Billion ≈ $12.55 Million |
+12.75% |
| 2010-03-31 | Rs1.03 Billion ≈ $11.13 Million |
-8.91% |
| 2009-03-31 | Rs1.13 Billion ≈ $12.22 Million |
-10.46% |
| 2008-03-31 | Rs1.26 Billion ≈ $13.65 Million |
-3.84% |
| 2007-03-31 | Rs1.31 Billion ≈ $14.19 Million |
-14.03% |
| 2006-03-31 | Rs1.53 Billion ≈ $16.51 Million |
-30.66% |
| 2005-03-31 | Rs2.20 Billion ≈ $23.81 Million |
-- |
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmintics, anti-convulsant, anti-spasmodic, etc. … Read more